Conmed (CNMD) Tops Q2 EPS by 88c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $51.98 +10.06%
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q2 EPS of ($0.07), $0.88 better than the analyst estimate of ($0.95). Revenue for the quarter came in at $157.8 million versus the consensus estimate of $126.59 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Medline Inc. (MDLN) Reports Q3 EPS of $0.44
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
